Iowa Yaz Lawsuit Information
Dozens of federal lawsuits alleging Yaz or Yasmin injury have been filed in at least nine jurisdictions and its is estimated that hundreds or even thousands of women currently have legal representation. These lawsuits all have common allegations that Yaz or Yasmin caused the plaintiff to suffer severe or fatal injuries, such as heart attacks, strokes, pulmonary embolism, deep vein thrombosis, gallbladder disease or sudden death.
Iowa Yaz & Yasmin Lawsuits ARE NOT Class Action Lawsuits
Because of the number of Yaz and Yasmin cases against Bayer Healthcare Pharmaceuticals, Inc. in many different jurisdictions, they have been be consolidated into a multidistrict ligitgation (MDL) for pretrial proceedings in the Southern District of Illinois. Unlike a class action lawsuit, where a large group of people collectively bring one claim through a class representative, a MDL is the combination of a large group of individual claims for coordinated discovery and scheduling. Although the Yaz and Yasmin lawsuits from across the United States will be centralized in a MDL for pretrial litigation, and the discovery will share many attributes with how a class action lawsuit over Yaz or Yasmin would be handled, the cases remain individual claims. Each plaintiff retains their own attorney and maintains the right to present their case to a jury in the district where the case was originally filed.
We represent all women suffering from Yaz lawsuit on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. For a free no-obligation consultation please fill out our short online contact form and one of our Yaz lawsuit attorneys will contact you to answer any of your questions.
Onder, Shelton, O'Leary & Peterson Partner Mark Niemeyer Named Co-Lead Counsel in Yaz MDL
Mark Niemeyer, a partner at Onder, Shelton, O’Leary & Peterson, LLC, has been appointed to the Plaintiffs' Steering Committee in the consolidated Yasmin and Yaz birth control litigation.
Mark Niemeyer, a partner with Onder, Shelton, O’Leary & Peterson, LLC, was appointed by U.S. District Judge David R. Herndon, who is presiding over the federal litigation for Yaz and Yasmin birth control (MDL No. 2100) in the U.S. District Court for the Southern District of Illinois, as Co-Lead Counsel to the Plaintiffs’ Steering Committee.
In some cases it is the families of women having died. The brief history of the best selling birth control pill in the United States contains multiple FDA warning letters, advertising retractions for minimizing risk and overstating benefits and a requirement to have all advertising through 2015 approved by the FDA. The FDA and Attorneys General of 27 states required Bayer HealthCare Pharmaceuticals, Inc., the maker of Yaz and Yasmin, to correct deceptive advertising, which minimized serious health risks to users and overstated the symptoms for which the drug was approved to treat. This prompted the company to launch a $20 million ad campaign to correct those misstatements and omissions. Click here to read information regarding Yasmin and Yaz FDA warning letters concerning Yasmin/Yaz advertising